Both in Biotechnology
Replimune Group vs Vor Biopharma
Over the past year REPL returned +199.5% and VOR returned −54.0%; their daily moves had a correlation of 0.07.
REPL +199.5% VOR −54.0%Growth of $1, one year, split-adjusted
| Metric | REPL | VOR |
|---|---|---|
| Price | $13.00 | $18.33 |
| Market cap | $1.22B | $1.08B |
| Today | +3.50% | +0.11% |
| 1 month | −16.1% | −19.1% |
| 6 months | +80.6% | +24.7% |
| Year to date | +33.7% | +40.1% |
| 1 year | — | −45.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 1.7× |
| Price / sales | — | — |
| Net cash | $86.6M | $466.1M |
| Dividend yield | — | — |
| Volatility (60d) | 192.2% | 65.8% |
| Short % of float | 36.1% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).